Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Aura Biosciences

Aura Biosciences Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
From Aura Biosciences
Via Business Wire
Tickers AURA
Aura Biosciences Presents Final Phase 1b/2 Data for its first Virus-Like Drug Conjugate, AU-011, in Patients with Choroidal Melanoma at the American Academy of Ophthalmology 2021 Annual Meeting
From Aura Biosciences
Via Business Wire
Tickers AURA
Aura Biosciences Presents Interim Phase 2 Safety Data Evaluating Suprachoroidal Administration of AU-011 in Patients with Choroidal Melanoma at the ASRS 2021 Annual Meeting
From Aura Biosciences
Via Business Wire
Aura Biosciences Expands Executive Leadership Team and Board of Directors
From Aura Biosciences
Via Business Wire
Aura Biosciences Assembles New Bladder Cancer Focused Scientific Advisory Board
From Aura Biosciences
Via Business Wire
Aura Biosciences Appoints Sapna Srivastava, Ph.D., to its Board of Directors
From Aura Biosciences
Via Business Wire
Aura Biosciences Presents New Preclinical AU-011 Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting
From Aura Biosciences
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.